Molecular subtypes in diffuse large B-cell lymphoma

Christian Gisselbrecht

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease. At the 20th Congress of the European Hematology Association (EHA), Christian Gisselbrecht, MD, of Paris Diderot University, Paris, France, explains the clinical significance of molecularly subtyping DLBCL as germinal center B-cell (GCB) or non-GCB (activated B cell-like).

Share this video  
Diffuse Large B-Cell Lymphoma
EHA 2015
12th June 2015
More from Christian Gisselbrecht
Future directions for the treatment of diffuse large B-cell lymphoma
Update on the clinical management of diffuse large B-cell lymphoma
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals